Results 131 to 140 of about 9,651 (201)

Coumarin-Based Prodrugs: Therapeutic Promise or Still Confined to Preclinical Exploration? [PDF]

Pharmaceutics
Chavez Alvarez AC, Moreau E.
europepmc   +1 more source

Anticancer selenopeptides from food sources: synthesis strategies and multitarget mechanisms. [PDF]

iScience
Ma M, Zhou X, Qiao X, Li L, Cheng S, Lu Y, Cheng H.   +6 more
europepmc   +1 more source

Potential application of mono-, dual-, and triple-target GLP-1 receptor agonists in improving the prognosis of patients with diabetic foot ulcers. [PDF]

Front Endocrinol (Lausanne)
Li Z, Wang X, He Y, Hu K, Liu Y, Zhang W, Ma Y, Jiang H.   +7 more
europepmc   +1 more source

Treatment-Related and Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor-Based Combination Therapies for Breast Cancer: A Systematic Review and Meta-Analysis. [PDF]

Thorac Cancer
Lu Y, Li H, Li K, Chen Y, Wang S.
europepmc   +1 more source

Multitarget Drugs: No-Donor Doxorubicins

, 2012
CHEGAEV, Konstantin, RIGANTI, Chiara, GAZZANO, Elena, ROLANDO, Barbara, FRUTTERO, Roberta, GASCO, Alberto   +5 more
openaire   +2 more sources

Natural Products in Cancer Prevention and Therapy: Current Challenges and Future Directions. [PDF]

MedComm (2020)
Qian R, Ge J, Fan N, Sun Z, Zhao C, Sun Y, Li Y, Li Y, Fu H.   +8 more
europepmc   +1 more source

Discontinued BACE1 Inhibitors in Phase II/III Clinical Trials and AM-6494 (Preclinical) Towards Alzheimer's Disease Therapy: Repurposing Through Network Pharmacology and Molecular Docking Approach. [PDF]

Pharmaceuticals (Basel)
Ugbaja SC, Kumalo HM, Gqaleni N.
europepmc   +1 more source

New multitarget antidiabetic potential agents based on sulfaguanidine: design, synthesis, and biological evaluation. [PDF]

RSC Adv
Ayoup MS, Kassab AE, Sonousi A, Eldaly SE, Al Nawah JY, Abdel-Hamid H, Ghareeb DA, Ashraf S, Fouad MA.   +8 more
europepmc   +1 more source

Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential. [PDF]

Biomedicines
Abdelsayed M, Boulaamane Y.
europepmc   +1 more source

Confronting the Antimicrobial Resistance Crisis in China: Emerging Superbugs, Genomic Surveillance, and Innovative Countermeasures. [PDF]

China CDC Wkly
Tong Q, Zeng L, Ge Y, Jia J.
europepmc   +1 more source